Get in contact

Please enter your details and our team will be in touch.

Please do not apply for job roles using the above form

All recruitment applications must be submitted via our hiring process. For open positions and applications, please visit our Careers page.

Visit us

Geneva

Geneva

Close

Rue François-Bellot 6, 1206

Nantes

Nantes

Close

Le Palace, 4 rue Voltaire, 44000

Paris

Paris

Close

14/16 Bd Poissonnière, 75009 Paris

London

London

Close

1 Pancras Sq, London N1C 4AG

Boston

Boston

Close

245 Main Street Cambridge MA 02142

New York

New York

Close

831 Broadway, Unit 3R, 10003

Meet us at an event

Our international team participates in a wide range of events around the world, providing opportunities for you to interact with our teams and discover more about our solutions.
Event
AACR: San Antonio Breast Cancer Summit
Dec 5, 2023
to
Dec 9, 2023
San Antonio, Texas

Meet us at Booth #741 at AACR: SABCS

Button
Congress
Digital Pathology and AI Congress Europe
Dec 7, 2023
to
Dec 8, 2023
London, UK

Come talk to us to explore how AI digital pathology could revolutionalize access to precision medicine for patients.

Button

Press kit

A selection of the Owkin team

Boilerplate

Owkin is an AI biotechnology company on a mission to find the right treatment for every patient. By understanding complex biology through AI, we identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools.

We use federated data access to unlock valuable insights from patient data while protecting patient privacy and securing proprietary data. We integrate the best of human and artificial intelligence to answer the research questions challenging biopharma and academic researchers.

Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $300 million and became a unicorn through investments from leading biopharma companies (Sanofi and BMS) and venture funds (Fidelity, GV and BPI, among others).

Media contact

Owkin’s experts are available to comment on topics related to medical research and Al.

For international media requests, please contact darius.meadon@owkin.com

For French media requests, please contact malika.labou-ext@owkin.com

About our founder

Thomas Clozel M.D.
Chief Executive Officer and co-founder

Thomas leads Owkin as CEO. He is a former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris and former member of Ari Melnick’s lab at the Weill Cornell Medical College. He ensures that patient health is prioritized when developing breakthrough medical technologies, bringing a patient-centric approach to each Owkin project.

FAQs

Where is Owkin based?
Close
What is Owkin's founding story?
Close
What makes Owkin different?
Close
What is federated learning?
Close
How does Owkin ensure data privacy and security?
Close
How does Substra protect data privacy?
Close
How much investment has Owkin received?
Close